About this trial
The Gastroparesis Registry 4 (GpR4) is an observational study of patients with symptoms of gastroparesis (Gp) and functional dyspepsia (FD) with either delayed or normal gastric emptying. To better understand these disorders, this registry will capture demographic, clinical, physiological, questionnaire, and patient outcome data to characterize the patients and their clinical course. Participants will complete several questionnaires, complete a nutrient drink test and have a gastric emptying study.
Eligibility criteria
Qualifiers
Age at least 18 years at initial screening visit
Symptoms of Gp and/or FD of at least 12-weeks duration with varying degrees of nausea, vomiting, early satiety, postprandial fullness, abdominal pain, abdominal burning. Thus, patients can enter the GpR4 registry primarily with abdominal pain suggesting FD-Epigastric Pain Syndrome.
Successful completion of gastric emptying scintigraphy of solids using the 4-hour Egg Beaters® protocol (or equivalent generic liquid egg white meal) within the last 9 months
Negative upper endoscopy or upper radiographic GI series within 5 years of registration
Disqualifiers
Use of narcotic analgesics greater than three days per week
Pyloric or intestinal obstruction as evidenced by EGD, UGI, or Abdominal CT
Active inflammatory bowel disease
Known eosinophilic gastroenteritis or eosinophilic esophagitis
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Johns Hopkins Bloomberg School of Public Health
Lead sponsor
Texas Tech University Health Sciences Center, El Paso
Collaborator
Temple University
Collaborator
University of Louisville
Collaborator
Mayo Clinic
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
Massachusetts General Hospital
Collaborator
Wake Forest University
Collaborator